共 50 条
- [1] Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on SNAr Electrophiles[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (08) : 6549 - 6569Schwarz, MoritzKurkunov, MaksymWittlinger, FlorianRudalska, RamonaWang, GuiqunSchwalm, Martin PeterRasch, AlexanderWagner, BenediktLaufer, Stefan A.Knapp, StefanDauch, DanielGehringer, Matthias
- [2] Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity in Models of Hepatocellular Carcinoma[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (10): : 1899 - 1904Liu, HaiboNiu, DeqiangSjin, Robert Tjin ThamDubrovskiy, AlexZhu, ZhendongMcDonald, Joseph J.Fahnoe, KellyWang, ZhigangMunson, MarkScholte, AndrewBarrague, MatthieuFitzgerald, MariaLiu, JinyuKothe, MichaelSun, FangxianMurtie, JoshuaGe, JieRocnik, JenniferHarvey, DarrenOspina, BeatrizPerron, KeliZheng, GangShehu, ElvisD'Agostino, Laura Akullian
- [3] Design, synthesis, and biological evaluation of selective covalent inhibitors of FGFR4[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 268Chen, XiaojuanLi, HuiliangLin, QianmengDai, ShuyanQu, LingzhiGuo, MingZhang, LinLiao, JiaxuanWei, HudieXu, GuangyuJiang, LongyingChen, Yongheng
- [4] Discovery and optimization of selective FGFR4 inhibitors via scaffold hopping[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (11) : 2420 - 2423Wang, YikaiChen, ZhengxiaDai, MeibiSun, PeipeiWang, ChunqiuGao, YangZhao, HaixiaZeng, WenqinShen, LiangMao, WeifengWang, TianHu, GuopingLi, JianChen, ShuhuiLong, ChaofengChen, XiaoxinLiu, JunhuaZhang, Yang
- [5] Design, synthesis, and anticancer evaluation of arylurea derivatives as potent and selective type II irreversible covalent FGFR4 inhibitors[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 87Wang, MinLan, LiWang, Yu-WeiZhang, Jin-YangShi, LeiSun, Li-Ping
- [6] Discovery of highly potent, selective, covalent inhibitors of JAK3[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (20) : 4622 - 4625Kempson, JamesOvalle, DamasoGuo, JunqingWrobleski, Stephen T.Lin, ShuqunSpergel, Steven H.Duan, James J. -W.Jiang, BinLu, ZhonghuiDas, JagabandhuYang, Bingwei V.Hynes, John, Jr.Wu, HongTokarski, JohnSack, John S.Khan, JavedSchieven, GaryBlatt, YuvalChaudhry, CharuSalter-Cid, Luisa M.Fura, AberraBarrish, Joel C.Carter, Percy H.Pitts, William J.
- [7] Design, synthesis and biological evaluation of quinazoline derivatives as potent and selective FGFR4 inhibitors[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 225Pan, ChenghaoNie, WenwenWang, JiaoDu, JiaminPan, ZhichaoGao, JianLu, YangChe, JinxinZhu, HongDai, HaibinChen, BinhuiHe, QiaojunDong, Xiaowu
- [8] Discovery of highly potent and selective covalent reversible cathepsin S inhibitors[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245Haap, WolfgangHartmann, GuidoSanchez, Ruben AlvarezAnselm, LilliBanner, David W.Ecabert, RobertGrether, UweKuehne, HolgerKuhn, BerndLuebbers, ThomasPeters, Jens-UwePlancher, Jean-MarcRufer, ArneSpinnler, Beat
- [9] Development of potent and specific inhibitors for oncogenic kinase FGFR4[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257Miranda, Renata RezendeZhang, Chao
- [10] Discovery of Potent and Selective Covalent Inhibitors of JNK[J]. CHEMISTRY & BIOLOGY, 2012, 19 (01): : 140 - 154Zhang, TinghuInesta-Vaquera, FranciscoNiepel, MarioZhang, JianmingFicarro, Scott B.Machleidt, ThomasXie, TingMarto, Jarrod A.Kim, NamDooSim, TaeboLaughlin, John D.Park, HajeungLoGrasso, Philip V.Patricelli, MattNomanbhoy, Tyzoon K.Sorger, Peter K.Alessi, Dario R.Gray, Nathanael S.